@hkumed @HKU_FMPC @HkuPharm @CSMPR_HKUPharm #HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #pharmacy #CommunityPharmacy #SymptomResolution #MinorAilment

The team: @Ranzhang_hku @IVANCHLAM Xinyi Liu Dr Feng Sun Prof Siyan Zhan Prof Kai Hang Yiu @ChuiCeline @Esther_CSMPRHKU @Prof_IanWong @CindyLan897569 @hkumed @HKU_FMPC @HkuPharm @CSMPR_HKUPharm #HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #TargetTrialEmulation #hypertension

@yukkam_yau Zhuoran Hu Meijiao Li @JianchaoQuan @sydney_tang @IvyMak_HKU @Prof_IanWong Dr David Chao Dr Welchie Ko Prof CS Lau @CindyLan897569 @hkumed @HKU_FMPC @HkuPharm @CSMPR_HKUPharm #HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #kidney #mortality #InterruptedTimeSeries

@hkumed @HKU_FMPC @HkuPharm @CSMPR_HKUPharm #HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #TargetTrialEmulation #hypertension #BloodPressure #guideline

The team: Tingting Chen @Boyuan_WANG_hku Ming Hin Lee Ka Hung Chan Prof Sophia Chan @snowly12191 @ChuiCeline @FranciscoTTLai1 @Esther_CSMPRHKU @Prof_IanWong @hkumed @HKU_FMPC @HkuPharm @CSMPR_HKUPharm #HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #smoking #tobacco #smoker

🚨BREAKING CONNECT DOTS JEFFREY EPSTEIN AND MIT MASSACHUSETTS INSTITUTE OF TECHNOLOGY In September, in response to revelations about engagements between MIT and Jeffrey Epstein, President Reif and the Executive Committee of the MIT Corporation asked MIT’s general counsel to retain a law firm to design and conduct a review of the facts surrounding those engagements. The general counsel retained the firm Goodwin Procter to lead the process and report to the Executive Committee and to President Reif. The review focused on what donations Epstein made to MIT; who in MIT’s senior leadership was aware of or approved the donations; when and why Epstein visited MIT; and whether MIT’s leadership was aware of or approved those visits. A: The Executive Committee of the MIT Corporation released Goodwin Procter’s full fact-finding report regarding MIT’s interactions with Jeffrey Epstein, as well as a statement. President Reif released a response. And MIT News published an article summarizing the materials, all of which are available here. The report names current and former professors who solicited funds from Epstein, people from outside MIT who played a role in soliciting such funds, current and former members of the senior administration, and every professor known to have met with Epstein on campus. The names of junior staffers and others whose actions were not central to the events are not named, so as to protect the privacy of those who may have engaged briefly with Epstein in the course of doing their jobs. In his letter to the community, President Reif called for decency, fairness, and understanding in return for the report’s transparency. On August 22, President Reif committed to contribute “an amount equal to the funds MIT received from any Epstein foundation to an appropriate charity that benefits his victims or other victims of sexual abuse.” At that time President Reif estimated that the donations were approximately $800,000. In the report we now see that the donations totaled $850,000.  Has MIT made this donation yet? If not, why not? And who is choosing the organizations? In the fall, President Reif asked MIT’s Committee on Sexual Misconduct Prevention and Response(CSMPR) to assess the landscape of charities that benefit survivors of sexual abuse and advise him on a suitable recipient for the donation. CSMPR is a faculty-led standing Institute committee of faculty, students, and staff, many of whom work closely with survivors of sexual abuse.  The Committee is diligently working to formulate a recommendation, which President Reif expects to receive shortly.  MIT will donate the full $850,000. When Epstein’s donations to MIT were revealed, MIT’s general counsel retained Goodwin Procter, a law firm that has worked with the Institute in the past and that has extensive experience conducting internal investigations at academic institutions. That background allowed the firm to get up to speed quickly as it began its review. Soon thereafter, the Executive Committee engaged the law firm Paul Weiss, which also has extensive experience leading internal investigations and advising boards of directors but no prior relationship with MIT.  From a governance perspective, the Executive Committee felt Paul Weiss’s independence from the Institute was valuable. Media reports suggested that Epstein was coded as “disqualified” in MIT’s donor system. Was he? And what does “disqualified” mean in this context? Contrary to media reports, Goodwin Procter’s review found that neither Epstein nor his foundations were ever coded as “disqualified” in MIT’s donor database. Further, the report notes that designation as “disqualified” does not mean that a person or entity is prohibited from donating to the Institute; rather, the term refers to any donor who is inactive or no longer interested in giving to MIT.

Thank you Prof. Ian Douglas and Dr. Angel Wong @LSHTM @ehr_lshtm for the lecture and workshop on target trial emulation #TTE with #CSMPR team today! @HkuPharm #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #drug #med #medication

@HKU_D24H and @HkuPharm will jointly organise a scientific #symposium themed “Collaborative Frontiers: Leveraging Partnerships to Advance Real-World Evidence” on 6 Nov, 2024 (Wed) at the Hong Kong Science Park. Register now: d24h.hk/reg/ #RWE #CSMPR #HKU #keynote

Our paper found that #SABA #overuse is associated with increased all-cause #mortality risk and frequency of hospital admissions among HK asthma patients. doi.org/10.1186/s12890-024-0… @HkuPharm #CSMPR #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #drug #med #medication

Our study on @BMCMedicine found that the risk of multiple different disease outcomes increased significantly with the severity of acute #COVID19 illness, especially in elderly. @HkuPharm #CSMPR #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #medication

The International #Conference on #ADHD will be held on 2 Nov (Sat) at #HKU. Register now for the event: adhda4a.hku.hk/registration/… #CSMPR #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #drug #med #medication #keynote #workshop #LancetPsychiatry

Members of CSMPR took part in oral presentations, poster sessions and meetings at the #ISPE's #ACPE in Tokyo. The team was excited to have exchanged experiences with fellows. @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research #pharmacoepidemiology #conference

Study by @Yi_Chai18 found that early intervention services #EIS was associated with reduced #selfharm and #suicide rates among all patients with first-episode #schizophrenia #FES. Full study: doi.org/10.1001/jamanetworko… @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research

Our study by @kpeng420 evaluated the cost-effectiveness of #Biosimilars vs #Leflunomide in Patients With #RheumatoidArthritis Read the full study: doi.org/10.1001/jamanetworko… @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #drug #med #medication

Our recent study by @jasondly proposed a new variant of the well-known Maximum Variance Unfolding #MVU method for a more effective supervised dimensionality reduction and data visualization. Read the full study: doi.org/10.1007/s10994-024-0… @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm

We visited @PKU1898 earlier this month for teaching and postgraduate research promotion! @Esther_CSMPRHKU @snowly12191 @FranciscoTTLai1 @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research #drugsafety #medsafety #drug #med #medication

Thank you Dr. Jeff Lange from Amgen for giving us a Good #Pharmacovigilance Practice #GPvP training! A crucial topic as expectations from drug regulatory agencies and the #pharmaceutical industry is rapidly evolving! @HkuPharm #CSMPR #HKU #pharmacy #research #drugsafety

Latest paper by @CLCheung37090 team unveiling the unique clinical #phenotypes of hip #fracture patients and the temporal association with #CardiovascularEvents #CVEs @NatureComms doi.org/10.1038/s41467-024-4… @HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research

Our recent paper investigating the benefits and risks of using #statins for primary prevention of #CardiovascularDiseases #CVDs and all-cause mortality in old and very old adults.@AnnalsofIM doi.org/10.7326/M24-00… @Wanchun_Xu @CindyLan897569 @EricWan_HKU #CSMPR #HKU #HKUMed

10 minutes to show our appreciation to frontline healthcare professionals - cards by students at North Point Government Primary School, Charlenespantry & #CSMPR @HkuPharm @VincentKCYan @ChrisYe22130103 @Edmund_Yiu @raineeyang_HKU @WeiYLuna @Faery_KANG @KyungJinLee19